Immunoadsorption in Guillain-Barre syndrome and myasthenia gravis

Therapeutic Apheresis

Volumn 4, Issue 3, 2000, Pages 195-197

  Haupt, W F ^a   Rosenow, F ^a   Van Der Ven, C ^a   Birkmann, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Guillain Barre syndrome; Immunoadsorption; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; HUMAN ALBUMIN; IMMUNOGLOBULIN; PHENYLALANINE; POLYVINYL ALCOHOL; TRYPTOPHAN;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEMYELINATING DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOADSORPTION; IMMUNOMODULATION; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOSORBENT TECHNIQUES; MYASTHENIA GRAVIS; PATIENT SELECTION; PLASMA EXCHANGE; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 0033922965     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2000.00183.x     Document Type: Conference Paper

References (12)

1. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27 (suppl):21-4.
2. The Guillain-Barré Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-1104.
3. French Cooperative Group on Plasma Exchange in Acute Guillain-Barré Syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: Role of replacement fluids. Ann Neurol 1987;22:753-61.
4. Haupt WF, Rosenow F, van der Ven C, Borberg H, Pawlik G. Sequential treatment of Guillain-Barré syndrome with extra-corporeal elimination and intravenous immunoglobulin. J Neurol Sci 1996;137:145-9.
5. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-30.
6. Pinching AJ, Peters DK, Newsome-Davis J. Remission of myasthenia gravis following plasma-exchange. Lancet 1976;2: 1373-6.
7. Besinger UA, Toyka KV, Hömberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A. Myasthenia gravis: Long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with change in disease severity. Neurology 1983;33:1316-21.
8. Drachman DB. Myasthenia gravis. New Engl J Med 1994;330: 1797-810.
9. Dau PC. Response to plasmapheresis and immunosuppressive drug therapy in 60 myasthenia gravis patients. Ann NY Acad Sci 1983;377:700-8.
10. Shibuya N, Sato T, Osame M, Takegami T, Doi S, Kawanami S. Immunoadsorption therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry 1994;57:578-81.
11. Grob D, Simpson D, Mitsumoto H et al. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995;45:38-344.
12. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997;41: 789-96.